20/20 Onsite

Point-of-need ophthalmic clinical trial solutions

United States · Founded 2014 · $8.0M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M Growth EquityMay 2021
Rounds
4

About

20/20 Onsite is a specialty clinical research organization providing end-to-end ophthalmic assessment services for sponsors and CROs conducting clinical trials with ocular endpoints. The company operates a nationwide fleet of point-of-need mobile ophthalmic units, enabling decentralized trial participation by bringing eye exams directly to patients rather than requiring them to travel to traditional clinical sites. With over 100,000 eye exams performed and 45+ clinical trials supported, 20/20 Onsite delivers single-call accountability for ocular endpoints across Phase 1 through Phase 3 studies, powered by a network of licensed optometrists.

Summary

20/20 Onsite is a Healthcare company based in United States, founded in 2014. It has raised $8.0M in total across 4 rounds, most recently a $8.0M Growth Equity round in May 2021. Investors include Morningside Group.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Growth EquityGrowth EquityMay 2021
$8.0M

Sign up to see all 4 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

20/20 Onsite on Indexed.vc
<a href="https://indexed.vc/companies/20-20-onsite"><img src="https://indexed.vc/api/badge/company/20-20-onsite" alt="20/20 Onsite on Indexed.vc" width="260" height="76" /></a>